Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,144 | 97,473 | 79,506 | 164,894 | 87,426 |
| Marketable Securities | 202,962 | 326,681 | 446,729 | 285,605 | 211,941 |
| Receivables | 69,021 | 51,132 | 52,749 | 138,912 | 183,857 |
| Other current assets | 26,444 | 32,559 | 48,889 | 22,549 | 40,392 |
| TOTAL | $353,571 | $507,845 | $627,873 | $611,960 | $523,616 |
| Non-Current Assets | |||||
| PPE Net | 105,549 | 83,464 | 81,353 | 62,287 | 40,199 |
| Investments And Advances | 570,351 | 423,571 | 326,648 | 485,047 | 132,502 |
| Intangibles | 157,033 | 165,108 | 293,670 | 86,811 | 0 |
| Other Non-Current Assets | 33,460 | 55,340 | 56,509 | 32,615 | 4,144 |
| TOTAL | $866,393 | $727,483 | $758,180 | $666,760 | $176,845 |
| Total Assets | $1,219,964 | $1,235,328 | $1,386,053 | $1,278,720 | $700,461 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 14,999 | 15,137 | 15,019 |
| Accounts payable and accrued liabilities | 18,364 | 15,360 | 23,093 | 20,494 | 26,488 |
| Accrued Expenses | 24,279 | 30,737 | 24,981 | 17,689 | 8,446 |
| Other current liabilities | 29,844 | 25,738 | 19,395 | 45,056 | 26,843 |
| TOTAL | $72,899 | $73,018 | $88,107 | $105,310 | $130,115 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12,648 | 28,476 | 29,551 | 8,655 | 959 |
| TOTAL | $17,906 | $29,024 | $28,071 | $7,530 | $959 |
| Total Liabilities | $90,805 | $102,042 | $116,178 | $112,840 | $131,074 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,829 | 29,785 | 29,519 | 30,253 | 28,874 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 590,467 | 633,175 | 801,000 | 657,597 | 150,881 |
| Other shareholders' equity | -4,437 | -1,610 | -17,713 | 6,372 | 438 |
| TOTAL | $1,129,159 | $1,133,286 | $1,269,875 | $1,165,880 | $569,387 |
| Total Liabilities And Equity | $1,219,964 | $1,235,328 | $1,386,053 | $1,278,720 | $700,461 |